2017 - GLP Comparison with GMP in Quality System -2017
Date2017-10-04
Deadline2017-10-03
VenueFremont, USA - United States
KeywordsLaboratory Managers; Quality Control Staff; Regulatory Affairs
Topics/Call fo Papers
Overview:
Good Laboratory Practice (GLP) is a quality system which intend for non-clinical studies and was revised by several bodies. GLP is a unique quality system in the sense it is intend for non-routine processes and activities.
Why should you Attend:
The authorities often required a GLP declaration and statement for submitted studies. Come to hear more on the requirements and particularly if you moving from another quality system like GMP or ISO 17025 to GLP, make the differences between these quality systems clear and prevent confusing especially if they are coexist in your site.
Areas Covered in the Session:
The Role and Responsibilities of the Study Director in GLP Studies
The Role and Responsibilities of the Sponsor in the Application of the Principles of GLP
Terms/Vocabulary
FDA GLP
21CFR 58
EPA GLP
Who Will Benefit:
Study Directors
Laboratory Managers
R&D Researchers of Pharmaceutical and Veterinary Companies
Quality Control Staff
Regulatory Affairs (RA) Staff
Speaker Profile:
Eyal Lerner is owner of ELC Consulting Services which offers the pharmaceutical and medical devices industries support in all quality related issues: Preparation for inspections, CAPA and RCA, quality manual QSM, self-inspection (internal audits), compliance gap analysis, 3rd party audits (FDF and API's), Management Review, GMP, GLP,MD: ISO 13485:2016 adjustments, DHF, DMR, V&V, 510k submission preparation and ISO 17025 (lab accreditation) and Validation.
Contact Detail:
Compliance4All DBA NetZealous,
Phone: +1-800-447-9407
Email: support-AT-compliance4All.com
Good Laboratory Practice (GLP) is a quality system which intend for non-clinical studies and was revised by several bodies. GLP is a unique quality system in the sense it is intend for non-routine processes and activities.
Why should you Attend:
The authorities often required a GLP declaration and statement for submitted studies. Come to hear more on the requirements and particularly if you moving from another quality system like GMP or ISO 17025 to GLP, make the differences between these quality systems clear and prevent confusing especially if they are coexist in your site.
Areas Covered in the Session:
The Role and Responsibilities of the Study Director in GLP Studies
The Role and Responsibilities of the Sponsor in the Application of the Principles of GLP
Terms/Vocabulary
FDA GLP
21CFR 58
EPA GLP
Who Will Benefit:
Study Directors
Laboratory Managers
R&D Researchers of Pharmaceutical and Veterinary Companies
Quality Control Staff
Regulatory Affairs (RA) Staff
Speaker Profile:
Eyal Lerner is owner of ELC Consulting Services which offers the pharmaceutical and medical devices industries support in all quality related issues: Preparation for inspections, CAPA and RCA, quality manual QSM, self-inspection (internal audits), compliance gap analysis, 3rd party audits (FDF and API's), Management Review, GMP, GLP,MD: ISO 13485:2016 adjustments, DHF, DMR, V&V, 510k submission preparation and ISO 17025 (lab accreditation) and Validation.
Contact Detail:
Compliance4All DBA NetZealous,
Phone: +1-800-447-9407
Email: support-AT-compliance4All.com
Other CFPs
- Seventh International Conference on Cloud Computing and eGovernance 2018
- 4th international Biomedical Engineering Conference
- 39th Annual Southwest Popular/American Culture Association Conference
- 2018 The CSI International Symposium on Real-Time and Embedded Systems and Technologies
- Canadian International Conference on Humanities & Social Sciences 2018
Last modified: 2017-08-10 15:57:16